Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
Bartlett, NL, Niedzwiecki, D, Johnson, JL, Friedberg, JW, Johnson, KB, van Besien, K, Zelenetz, AD, Cheson, BD, Canellos, GP
Published in Annals of oncology (01.06.2007)
Published in Annals of oncology (01.06.2007)
Get full text
Journal Article
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices
Nooka, A.K., Nabhan, C., Zhou, X., Taylor, M.D., Byrtek, M., Miller, T.P., Friedberg, J.W., Zelenetz, A.D., Link, B.K., Cerhan, J.R., Dillon, H., Sinha, R., Shenoy, P.J., Levy, D., Dawson, K., Hirata, J.H., Flowers, C.R.
Published in Annals of oncology (01.02.2013)
Published in Annals of oncology (01.02.2013)
Get full text
Journal Article
A Phase 1b 2 trial of mapatumumab in patients with relapsed refractory non-Hodgkin's lymphoma
Younes, A, Vose, J M, Zelenetz, A D, Smith, M R, Burris, H A, Ansell, S M, Klein, J, Halpern, W, Miceli, R, Kumm, E, Fox, N L, Czuczman, M S
Published in British journal of cancer (07.12.2010)
Published in British journal of cancer (07.12.2010)
Get full text
Journal Article
Treatment outcomes of Limited Stage Grade 3A Follicular Lymphoma
Sarkar, R. R., Lee, J., Zhang, Z., Zelenetz, A., Salles, G., Yahalom, J., Imber, B.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma
Schaffel, R., Hedvat, C. V., Teruya-Feldstein, J., Persky, D., Maragulia, J., Lin, D., Portlock, C. S., Moskowitz, C. H., Zelenetz, A. D.
Published in Annals of oncology (2010)
Published in Annals of oncology (2010)
Get full text
Journal Article
Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification
Matasar, M.J., Shi, W., Silberstien, J., Lin, O., Busam, K.J., Teruya-Feldstein, J., Filippa, D.A., Zelenetz, A.D., Noy, A.
Published in Annals of oncology (01.01.2012)
Published in Annals of oncology (01.01.2012)
Get full text
Journal Article
Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
Liedtke, M., Hamlin, P.A., Moskowitz, C.H., Zelenetz, A.D.
Published in Annals of oncology (01.06.2006)
Published in Annals of oncology (01.06.2006)
Get full text
Journal Article
Indications for and efficacy of splenectomy for haematological disorders
Bickenbach, K. A., Gonen, M., Labow, D. M., Strong, V., Heaney, M. L., Zelenetz, A. D., Coit, D. G.
Published in British journal of surgery (01.05.2013)
Published in British journal of surgery (01.05.2013)
Get full text
Journal Article
Genetic Alterations in Follicular Lymphoma Predict Response to Very Low Dose Radiotherapy
Wijetunga, N. A., Lebow, E., Chan, A., Lee, J., Fregonese, B., Hajj, C., Cedarquist, G., Hubbeling, H., Ma, J., Sarkar, R., Tringale, K., Joffe, E., Dogan, A., Zelenetz, A. D., Salles, G., Imber, B. S., Yahalom, J.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study
Casulo, C., Day, B., Dawson, K.L., Zhou, X., Flowers, C.R., Farber, C.M., Hainsworth, J.D., Cerhan, J.R., Link, B.K., Zelenetz, A.D., Friedberg, J.W.
Published in Annals of oncology (01.11.2015)
Published in Annals of oncology (01.11.2015)
Get full text
Journal Article
PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS, SUBGROUP ANALYSIS FROM BRUIN WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT
Cheah, C. Y., Shah, N. N., Jurczak, W., Zinzani, P. Luigi, Eyre, T. A., Ujjani, C. S., Izutsu, K., Ma, S., Flinn, I., Alencar, A. J., Lewis, D., Patel, K., Maddocks, K., Wang, Y., Munir, T., Zelenetz, A. D., Balbas, M., Tsai, D. E., Wang, C., Wang, M. L.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)
Dabaja, B.S., Zelenetz, A.D., Ng, A.K., Tsang, R.W., Qi, S., Allen, P.K., Hodgson, D., Ricardi, U., Hoppe, R.T., Advani, R., Mauch, P.M., Constine, L.S., Specht, L., Li, Y., Terezakis, S.A., Wirth, A., Reinartz, G., Eich, H.T., Aleman, B.M.P., Barr, P., Yahalom, J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas
KAMINSKI, Mark S, ZELENETZ, Andrew D, WAHL, Richard L, KNOX, Susan J, VOSE, Julie M, PRESS, Oliver W, SALEH, Mansoor, LEONARD, John, FEHRENBACHER, Louis, LISTER, T. Andrew, STAGG, Robert J, TIDMARSH, George F, KROLL, Stew
Published in Journal of clinical oncology (01.10.2001)
Published in Journal of clinical oncology (01.10.2001)
Get full text
Journal Article
PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma
Moskowitz, A., Savage, K., Feldman, T., Ganesan, N., Hancock, H., Davey, T., Perez, L., Santarosa, A., Subzwari, S., Capadona, C., Yang, C., Galasso, N., David, K., Epstein‐Peterson, Z., Khan, N., Kumar, A., Hamlin, P., Ghione, P., Lue, J., Straus, D., Zelenetz, A., Owens, C., Caron, P., Intlekofer, A., Horwitz, S., Falchi, L., Johnson, W., Palomba, M. L., Noy, A., Salles, G., Torka, P., Vardhana, S., Yahalom, J., Dogan, A., Schoder, H.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PHASE I STUDY OF BENDAMUSTINE, RITUXIMAB, IBRUTINIB, AND VENETOCLAX IN RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA
Kumar, A., Batlevi, C., Drullinsky, P., Grieve, C., Laraque, L., Joseph, A., Mahajan, N., Matasar, M., Straus, D., Zelenetz, A., Hamlin, P.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
ZANDELISIB, A PI3Kδ INHIBITOR ON INTERMITTENT SCHEDULE (IS) IN FOLLICULAR LYMPHOMA PATIENTS WHO PROGRESSED WITHIN 24 MONTHS OF FIRST‐LINE CHEMOIMUNOTHERAPY (POD24)
Pagel, J., Reddy, N., Jagadeesh, D., Stathis, A., Asch, A. S., Salman, H., Kenkre, V. P., Soumerai, J. D., Llorin‐Sangalang, J., Gorbatchevsky, I., Li, J., Zelenetz, A. D.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
BENDAMUSTINE, RITUXIMAB, AND POLATUZUMAB VEDOTIN FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: SINGLE‐CENTER REAL‐WORLD EXPERIENCE
Farina, K. A, Drill, E, Buie, L. W, Falchi, L, Kumar, A, Noy, A, Palomba, M L, Salles, G, Straus, D. J, Zelenetz, A. D, Buege, M. J, Batlevi, C. L
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX (BOVEN) IN PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL
Soumerai, J. D., Dogan, A., Seshan, V., Flaherty, K., Carter, J., Hochberg, E., Barnes, J. A., Abramson, J. S., Hamilton, A. M., Noy, A., Owens, C. N., Palomba, M. L., Kumar, A., Roeker, L. E., Thompson, M., Takvorian, R. W., Epstein‐Peterson, Z., Geyer, M., Ramos‐Amador, W., Mahajan, N., Martignetti, R., Plummer, S. F., Mi, J., Lynch, J. M., McGree, B. M., Sherburne, M. M., Patterson, E. N., Slupe, N., Chabowska, M., Labarre, A., Choma, M., McCambridge, G., Kelly, H., Devlin, M. C., Puccio, M. G., Garcia, R. N., Grieve, C., Cohen, A., Biondo, J., Jacob, A., Abdel‐Wahab, O., Zelenetz, A. D.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin’s lymphoma
Zelenetz, A. D., Hamlin, P., Kewalramani, T., Yahalom, J., Nimer, S., Moskowitz, C. H.
Published in Annals of oncology (01.01.2003)
Published in Annals of oncology (01.01.2003)
Get full text
Journal Article
Conference Proceeding
Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma
KEWALRAMANI, T, NIMER, S. D, ZELENETZ, A. D, MALHOTRA, S, QIN, J, YAHALOM, J, MOSKOWITZ, C. H
Published in Bone marrow transplantation (Basingstoke) (01.10.2003)
Published in Bone marrow transplantation (Basingstoke) (01.10.2003)
Get full text
Journal Article